Morgan Stanley’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $23.2M | Buy |
638,879
+12,479
| +2% | +$454K | ﹤0.01% | 2654 |
|
2025
Q1 | $22.7M | Buy |
626,400
+28,211
| +5% | +$1.02M | ﹤0.01% | 2565 |
|
2024
Q4 | $25.2M | Buy |
598,189
+130,353
| +28% | +$5.48M | ﹤0.01% | 2538 |
|
2024
Q3 | $26M | Sell |
467,836
-30,133
| -6% | -$1.67M | ﹤0.01% | 2517 |
|
2024
Q2 | $20.5M | Sell |
497,969
-6,413
| -1% | -$264K | ﹤0.01% | 2639 |
|
2024
Q1 | $23.5M | Sell |
504,382
-690,716
| -58% | -$32.2M | ﹤0.01% | 2518 |
|
2023
Q4 | $57.1M | Buy |
1,195,098
+699,609
| +141% | +$33.5M | ﹤0.01% | 2295 |
|
2023
Q3 | $17.7M | Sell |
495,489
-21,686
| -4% | -$773K | ﹤0.01% | 2596 |
|
2023
Q2 | $23.9M | Buy |
517,175
+158,765
| +44% | +$7.32M | ﹤0.01% | 2296 |
|
2023
Q1 | $14.4M | Buy |
358,410
+50,063
| +16% | +$2.01M | ﹤0.01% | 2787 |
|
2022
Q4 | $14.3M | Sell |
308,347
-91,766
| -23% | -$4.25M | ﹤0.01% | 2692 |
|
2022
Q3 | $16.6M | Buy |
400,113
+70,464
| +21% | +$2.92M | ﹤0.01% | 2407 |
|
2022
Q2 | $19.7M | Buy |
329,649
+84,910
| +35% | +$5.07M | ﹤0.01% | 2309 |
|
2022
Q1 | $17.8M | Buy |
244,739
+52,735
| +27% | +$3.83M | ﹤0.01% | 2244 |
|
2021
Q4 | $16.1M | Sell |
192,004
-37,065
| -16% | -$3.12M | ﹤0.01% | 2397 |
|
2021
Q3 | $20.7M | Sell |
229,069
-161,029
| -41% | -$14.5M | ﹤0.01% | 2052 |
|
2021
Q2 | $37.2M | Buy |
390,098
+152,916
| +64% | +$14.6M | ﹤0.01% | 1552 |
|
2021
Q1 | $27M | Sell |
237,182
-14,146
| -6% | -$1.61M | ﹤0.01% | 1648 |
|
2020
Q4 | $34.8M | Buy |
251,328
+129,855
| +107% | +$18M | 0.01% | 1366 |
|
2020
Q3 | $9.98M | Buy |
121,473
+27,170
| +29% | +$2.23M | ﹤0.01% | 2032 |
|
2020
Q2 | $7.38M | Buy |
94,303
+13,688
| +17% | +$1.07M | ﹤0.01% | 2265 |
|
2020
Q1 | $3.58M | Sell |
80,615
-75,895
| -48% | -$3.37M | ﹤0.01% | 2777 |
|
2019
Q4 | $6.68M | Buy |
156,510
+16,850
| +12% | +$720K | ﹤0.01% | 2868 |
|
2019
Q3 | $5.97M | Buy |
139,660
+55,492
| +66% | +$2.37M | ﹤0.01% | 2669 |
|
2019
Q2 | $5.35M | Buy |
84,168
+61,549
| +272% | +$3.91M | ﹤0.01% | 2857 |
|
2019
Q1 | $1.57M | Sell |
22,619
-124,619
| -85% | -$8.64M | ﹤0.01% | 3786 |
|
2018
Q4 | $6.4M | Sell |
147,238
-3,950
| -3% | -$172K | ﹤0.01% | 2596 |
|
2018
Q3 | $11.5M | Sell |
151,188
-34,247
| -18% | -$2.61M | ﹤0.01% | 2266 |
|
2018
Q2 | $14.3M | Buy |
185,435
+68,812
| +59% | +$5.29M | ﹤0.01% | 1985 |
|
2018
Q1 | $5.95M | Buy |
116,623
+21,984
| +23% | +$1.12M | ﹤0.01% | 2847 |
|
2017
Q4 | $4.39M | Buy |
94,639
+11,890
| +14% | +$551K | ﹤0.01% | 3251 |
|
2017
Q3 | $4.41M | Buy |
82,749
+16,128
| +24% | +$859K | ﹤0.01% | 3094 |
|
2017
Q2 | $4.14M | Sell |
66,621
-9,487
| -12% | -$589K | ﹤0.01% | 3048 |
|
2017
Q1 | $5.16M | Sell |
76,108
-59,952
| -44% | -$4.06M | ﹤0.01% | 2835 |
|
2016
Q4 | $9.57M | Buy |
136,060
+86,127
| +172% | +$6.06M | ﹤0.01% | 2300 |
|
2016
Q3 | $3.54M | Buy |
49,933
+17,272
| +53% | +$1.22M | ﹤0.01% | 3004 |
|
2016
Q2 | $1.6M | Buy |
32,661
+3,469
| +12% | +$170K | ﹤0.01% | 3605 |
|
2016
Q1 | $1.85M | Sell |
29,192
-1,489
| -5% | -$94.3K | ﹤0.01% | 3413 |
|
2015
Q4 | $3.44M | Sell |
30,681
-6,794
| -18% | -$762K | ﹤0.01% | 3029 |
|
2015
Q3 | $3.61M | Sell |
37,475
-16,289
| -30% | -$1.57M | ﹤0.01% | 2938 |
|
2015
Q2 | $5.51M | Sell |
53,764
-17,228
| -24% | -$1.76M | ﹤0.01% | 2704 |
|
2015
Q1 | $4.41M | Buy |
70,992
+3,831
| +6% | +$238K | ﹤0.01% | 2869 |
|
2014
Q4 | $2.95M | Sell |
67,161
-2,219
| -3% | -$97.4K | ﹤0.01% | 3217 |
|
2014
Q3 | $3.93M | Buy |
69,380
+25,226
| +57% | +$1.43M | ﹤0.01% | 2842 |
|
2014
Q2 | $1.98M | Sell |
44,154
-37,951
| -46% | -$1.7M | ﹤0.01% | 3488 |
|
2014
Q1 | $4.01M | Buy |
+82,105
| New | +$4.01M | ﹤0.01% | 2781 |
|